Quarterly Financial Data (Unaudited)

12 Months Ended

Dec. 31, 2020

Quarterly Financial Information Disclosure [Abstract]

Our quarterly financial statements are prepared on the same basis as the audited annual financial statements, and include all adjustments necessary for the fair statement of our results of operations for these periods.


	For the Three Months Ended
	Successor
	March 31,		June 30,		September 30,		December 31,
2020
Revenue (1)	$	395.3	$	420.6	$	442.1	$	480.1
Operating income (loss) (2)	$	(8.3)	$	(1.4)	$	45.2	$	27.5
Net income (loss) (3)(4)	$	73.9	$	(173.8)	$	(14.9)	$	8.3
Net (income) loss attributable to the non-controlling interest	$	(0.4)	$	(1.2)	$	(2.1)	$	(1.3)
Net income (loss) attributable to Dun & Bradstreet Holdings, Inc. (Successor)	$	41.5	$	(207.1)	$	(17.0)	$	7.0

(1)Includes a reduction of revenue of $17.4 million for the three months ended March 31, 2020 due to deferred revenue purchase accounting adjustment in connection with the Take-Private Transaction.

(2)Included within selling and administrative expenses is an expense of $20.0 million for the three months ended June 30, 2020, related to stock option expense in connection with the IPO.

(3)Includes an expense within non-operating expense-net of $41.3 million and $25.5 million in the three months ended June 30, 2020 and September 30, 2020, respectively, related to the premium paid and the write-off of the associated debt issuance cost and discount as a result of the partial redemption of our senior secured and unsecured notes (see Note 6).

(4)Includes within non-operating expense-net a gain of $69.8 million for the three months ended March 31, 2020, and an expense of $102.6 million for the three months ended June 30, 2020 related to the change in fair value of make-whole derivative liability.


			For the Three Months Ended
	Predecessor		Successor
	Period from January 1 to February 7, 2019		March 31,		June 30,		September 30,		December 31,
2019
Revenue (1)	$	178.7	$	174.1	$	398.9	$	408.2	$	432.7
Operating loss (2)	$	(11.6)	$	(202.9)	$	(9.1)	$	(1.0)	$	(7.0)
Net loss (3)	$	(74.8)	$	(209.6)	$	(60.5)	$	(55.3)	$	(228.1)
Net (income) loss attributable to the non-controlling interest	$	(0.8)	$	(0.4)	$	(1.5)	$	(1.4)	$	(3.2)
Net loss attributable to Dun & Bradstreet Holdings, Inc. (Successor) / The Dun & Bradstreet Corporation (Predecessor)	$	(75.6)	$	(227.9)	$	(94.0)	$	(88.8)	$	(263.3)

(1)Includes a reduction of revenue of $39.6 million, $39.2 million, $38.0 million, and $22.1 million for the three months ended March 31, June 30, September 30, and December 31, 2019 (Successor), respectively and excludes revenue of $25.9 million for the period from January 1 to February 7, 2019 (Predecessor) due to International lag adjustment also in connection with the Take-Private Transaction.

(2)Includes transaction costs of $147.4 million and $52.0 million directly attributable to the Take-Private Transaction for the Successor three months ended March 31, 2019 and the Predecessor period from January 1 to February 7, 2019, respectively. In addition, for the Predecessor period from January 1 to February 7, 2019, we incurred $10.4 million to accelerate the vesting of equity-based grants as a result of the Take-Private Transaction. We also incurred higher amortization for the Successor periods associated with recognized intangible assets resulting from the Take-Private Transaction. See Note 15 and 16.

(3)Includes an expense within non-operating expense-net of $85.8 million to settle a portion of the U.S. Non-Qualified plans in the Predecessor period from January 1, 2019 to February 7, 2019 as a result of the Take-Private Transaction and an expense of $172.4 million in the three months ended December 31, 2019 (Successor) related to the change in fair value of make-whole derivative liability.